AdaptHealth To Participate in Upcoming Investor Conferences
Business Wire (Fri, 11-Sep 1:00 PM ET)
TipRanks (Wed, 9-Sep 8:50 AM ET)
Canaccord Genuity Reaffirms Their Buy Rating on AdaptHealth (AHCO)
TipRanks (Wed, 9-Sep 7:37 AM ET)
AdaptHealth Appoints Harriss Currie as Chief Financial Officer
Business Wire (Tue, 8-Sep 4:00 PM ET)
ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health
PRNewswire (Mon, 17-Aug 9:00 AM ET)
Globe Newswire (Fri, 14-Aug 7:44 PM ET)
AdaptHealth Corp. (AHCO) Securities Investigation Notice - Levi & Korsinsky
PRNewswire (Wed, 12-Aug 10:09 AM ET)
Globe Newswire (Mon, 10-Aug 12:56 PM ET)
AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law
Business Wire (Sat, 8-Aug 3:35 PM ET)
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
Business Wire (Fri, 7-Aug 4:05 PM ET)
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
Adapthealth Corp. trades on the NASDAQ stock market under the symbol AHCO.
As of September 14, 2026, AHCO stock price declined to $5.88 with 3,490,041 million shares trading.
AHCO has a beta of -1.41, meaning it tends to be less sensitive to market movements. AHCO has a correlation of 0.05 to the broad based SPY ETF.
AHCO has a market cap of $784.45 million. This is considered a Small Cap stock.
Last quarter Adapthealth Corp. reported $740 million in Revenue and $.08 earnings per share. This fell short of revenue expectation by $-111 million and missed earnings estimates by -$.04.
In the last 3 years, AHCO traded as high as $13.43 and as low as $5.21.
The top ETF exchange traded funds that AHCO belongs to (by Net Assets): IJR, VTI, VB, VBR, IWM.
AHCO has underperformed the market in the last year with a return of -38.3%, while the SPY ETF gained +16.8%. In the last 3 month period, AHCO fell short of the market, returning -41.8%, while SPY returned +3.4%. However, in the most recent 2 weeks AHCO has outperformed the stock market by returning +1.6%, while SPY returned -1.1%.
AHCO support price is $5.85 and resistance is $6.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AHCO shares will trade within this expected range on the day.